Phibro Animal Health (PAHC) FY2016 results: revenue $752 million, up 0.4% on the year
Phibro Animal Health Corp. (PAHC) reported revenue of $752 million for fiscal 2016, the year ended 30 June 2016, up 0.4% on the year before. Net income was $83 million, up 37.2%, and diluted earnings per share $2.07. The figures are the company's own, from the 10-K it filed with the SEC on 29 August 2016.
Revenue
$752 million
+0.4% on the year
FY2012FY2016
Operating margin
11.4%
11.7% a year earlier
FY2012FY2016
Net income
$83 million
+37.2% on the year
FY2012FY2016
Diluted EPS
$2.07
+37.1% on the year
FY2012FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Revenue
752
749
692
+0.4%
Cost of revenue
512
515
488
-0.5%
Gross profit
239
233
204
+2.5%
Gross margin
31.8%
31.2%
29.5%
Research and development
11.0
9.5
8.2
+16.0%
Selling, general and administrative
153
146
141
+5.3%
Operating income
85.7
87.7
63.8
-2.2%
Operating margin
11.4%
11.7%
9.2%
Interest expense
16.8
14.6
29.9
+15.8%
Pre-tax income
76.8
78.8
6.3
-2.5%
Income tax
-6.0
18.5
9.4
Effective tax rate
-7.8%
23.5%
149.6%
Net income
82.7
60.3
-3.1
+37.2%
Net margin
11.0%
8.1%
-0.5%
Diluted EPS
$2.07
$1.51
-$0.10
+37.1%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Operating cash flow
37.2
68.7
-0.7
-45.8%
Capital expenditure
36.4
20.1
19.8
+81.2%
Free cash flow
0.9
48.6
-20.6
-98.2%
Free cash flow margin
0.1%
6.5%
-3.0%
Cash from investing
-82.8
n/a
n/a
Cash from financing
50.4
n/a
n/a
Depreciation and amortisation
23.5
21.6
21.5
+8.6%
Dividends paid
15.7
15.6
25.0
+0.7%
Dividend per share
$0.40
$0.40
$0.82
0.0%
Diluted shares, weighted
40m
40m
32m
+0.4%
Balance sheet
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Shareholders' equity
90.5
29.6
15.1
+205.4%
Deposits
-6.0
-0.5
n/a
Debt
350
290
289
+20.9%
Other liabilities
173
175
168
-0.9%
Total liabilities and equity
608
493
472
+23.2%
Fixed assets
127
104
109
+21.9%
Goodwill
21.1
12.6
12.6
+67.5%
Intangible assets
60.1
37.3
29.8
+61.2%
Cash and equivalents
33.6
29.2
11.8
+15.0%
Receivables
124
111
114
+11.4%
Inventory
168
150
143
+12.0%
Other assets
74.2
48.9
51.9
+51.7%
Total assets
608
493
472
+23.2%
10-K for the year ended 30 June 2016, filed 29 August 2016: the filing.